To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed Keros Therapeutics goes public
Lexington, Massachusetts-based Keros Therapeutics, a developer of treatments for suffering from hematological and musculoskeletal disorders, has raised $96 million for its IPO after pricing its 6 million shares at $16 per share.
